2025-21189Notice

Importer of Controlled Substances Application: Fisher Clinical Services, Inc.

Published Date: 11/26/2025

Notice

Summary

Fisher Clinical Services, Inc. wants to become an official importer of certain controlled substances like marijuana and its extracts. This affects companies involved in drug manufacturing and importation, who can comment or request a hearing by December 26, 2025. No direct costs are mentioned, but the decision could impact how these substances enter the U.S. market.

Analyzed Economic Effects

3 provisions identified: 2 benefits, 1 costs, 0 mixed.

No Commercial Finished Dosage Imports Allowed

The registration, if approved, will not authorize importation of Food and Drug Administration‑approved or non‑approved finished dosage forms for commercial sale; approval is limited to activities consistent with 21 U.S.C. 952(a)(2).

Deadline to Comment or Request Hearing

If you are a registered bulk manufacturer or an applicant, you may submit electronic comments or objections, or file a written request for a hearing, by December 26, 2025. Comments must be submitted through https://www.regulations.gov and hearing requests must also be mailed to the Drug Enforcement Administration addresses listed in the notice.

Application to Import Specific Controlled Substances

Fisher Clinical Services, Inc. applied on August 26, 2025 to be registered to import specific Schedule I and II substances — including marihuana, marihuana extract, tetrahydrocannabinols, 5‑MeO‑DMT, DMT, psilocybin, methylphenidate, levorphanol, noroxymorphone, and tapentadol — and says it plans to import them for use in clinical trials only.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
11/26/2025
12/26/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in